Drägerwerk AG & Co. KGaA (FRA:DRW3)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,177	818	900	723	1,020	1,141
Market Cap Growth	31.86%	-9.02%	24.38%	-29.08%	-10.62%	38.64%
Enterprise Value	1,448	1,021	1,179	817	758	1,072
Last Close Price	68.00	45.09	47.76	40.05	49.88	58.25
PE Ratio	11.79	6.58	8.15	-	7.59	6.05
PS Ratio	0.35	0.24	0.27	0.24	0.31	0.34
PB Ratio	0.80	0.53	0.64	0.55	0.81	1.10
P/TBV Ratio	1.05	0.69	0.85	0.75	1.12	1.62
P/FCF Ratio	9.24	4.89	7.22	-	3.60	3.26
P/OCF Ratio	6.18	4.89	4.74	-	2.65	2.48
EV/Sales Ratio	0.43	0.30	0.35	0.27	0.23	0.32
EV/EBITDA Ratio	5.30	3.51	4.71	-	2.03	2.25
EV/EBIT Ratio	12.00	4.89	7.15	-	2.78	2.69
EV/FCF Ratio	11.37	6.10	9.46	-	2.67	3.06
Debt / Equity Ratio	0.31	0.18	0.33	0.27	0.28	0.36
Debt / EBITDA Ratio	1.60	0.93	1.59	8.55	0.84	0.72
Debt / FCF Ratio	3.51	1.62	3.78	-	1.23	1.06
Asset Turnover	1.12	1.09	1.09	0.97	1.03	1.16
Inventory Turnover	2.58	2.82	2.83	2.75	2.89	3.25
Quick Ratio	0.93	1.13	1.13	0.93	1.41	1.26
Current Ratio	1.74	1.93	1.83	1.56	2.13	1.86
Return on Equity (ROE)	6.89%	8.47%	8.21%	-4.93%	13.45%	23.68%
Return on Assets (ROA)	2.63%	4.22%	3.33%	-1.80%	5.25%	8.49%
Return on Capital (ROIC)	4.15%	7.07%	5.79%	-3.43%	11.29%	17.86%
Return on Capital Employed (ROCE)	6.40%	9.90%	8.00%	-	12.10%	18.50%
Earnings Yield	8.48%	15.20%	12.28%	-8.93%	15.12%	21.92%
FCF Yield	10.82%	20.44%	13.85%	-30.96%	27.81%	30.67%
Dividend Yield	2.94%	4.50%	3.77%	0.47%	0.38%	0.33%
Payout Ratio	37.52%	26.65%	3.33%	-	2.63%	2.18%
Buyback Yield / Dilution	-	0.03%	-	-	-1.66%	-3.90%
Total Shareholder Return	2.94%	4.54%	3.77%	0.47%	-1.28%	-3.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.